Atrás
59
27
También listada como
OPHLY
OTC
Rango del Día
$14.00
$16.00
Rango de 52 Semanas
$9.20
$18.67
Volumen
625
Promedio 50D / 200D
$15.37
/
$12.48
Cierre Anterior
$14.00
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (627 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | 0.1 | 0.4 |
| P/B | 0.0 | 2.9 |
| ROE % | 6.4 | 3.7 |
| Net Margin % | 10.3 | 3.9 |
| Rev Growth 5Y % | 12.0 | 10.0 |
| D/E | 0.2 | 0.2 |
Precio Objetivo de Analistas
No hay cobertura de analistas disponible
Estimaciones de Ganancias
| Período | EPS Est. | Ingresos Est. | Analistas |
|---|---|---|---|
| FY2030 |
$133.84
$122.73 – $144.81
|
470 B | 1 |
| FY2029 |
$130.53
$119.70 – $141.24
|
470 B | 1 |
| FY2028 |
$120.40
$110.41 – $130.27
|
450 B | 1 |
Puntos Clave
Revenue grew 12.01% annually over 5 years — strong growth
Earnings declined -60.89% over the past year
Debt/Equity of 0.19 — conservative balance sheet
Generating 74.47B in free cash flow
P/E of 0.13 — trading at a low valuation
Revenue growth is decelerating — 1Y growth trails 5Y average by 15.15%
Crecimiento
Revenue Growth (5Y)
12.01%
Revenue (1Y)-3.14%
Earnings (1Y)-60.89%
FCF Growth (3Y)-28.36%
Calidad
Return on Equity
6.35%
ROIC4.82%
Net Margin10.28%
Op. Margin12.27%
Seguridad
Debt / Equity
0.19
Current Ratio3.07
Interest Coverage11.23
Valoración
P/E Ratio
0.13
P/B Ratio0.01
EV/EBITDA-0.86
Dividend Yield0.05%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -3.14% | Revenue Growth (3Y) | 4.34% |
| Earnings Growth (1Y) | -60.89% | Earnings Growth (3Y) | -33.37% |
| Revenue Growth (5Y) | 12.01% | Earnings Growth (5Y) | -9.75% |
| Profitability | |||
| Revenue (TTM) | 486.87B | Net Income (TTM) | 50.05B |
| ROE | 6.35% | ROA | 4.70% |
| Gross Margin | 69.61% | Operating Margin | 12.27% |
| Net Margin | 10.28% | Free Cash Flow (TTM) | 74.47B |
| ROIC | 4.82% | FCF Growth (3Y) | -28.36% |
| Safety | |||
| Debt / Equity | 0.19 | Current Ratio | 3.07 |
| Interest Coverage | 11.23 | Dividend Yield | 0.05% |
| Valuation | |||
| P/E Ratio | 0.13 | P/B Ratio | 0.01 |
| P/S Ratio | 0.01 | PEG Ratio | -0.26 |
| EV/EBITDA | -0.86 | Dividend Yield | 0.05% |
| Market Cap | 6.58B | Enterprise Value | -51.31B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 486.87B | 502.67B | 447.19B | 361.36B | 309.28B |
| Net Income | 50.05B | 127.98B | 112.72B | 80.52B | 75.43B |
| EPS (Diluted) | 106.41 | 266.60 | 230.79 | 162.16 | 151.09 |
| Gross Profit | 338.92B | 375.55B | 337.13B | 267.85B | 223.71B |
| Operating Income | 59.75B | 163.10B | 152.29B | 114.91B | 92.10B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1.06T | 913.67B | 882.44B | 739.20B | 746.84B |
| Total Liabilities | 275.84B | 115.06B | 134.62B | 77.53B | 105.69B |
| Shareholders' Equity | 782.45B | 792.96B | 741.87B | 655.91B | 635.55B |
| Total Debt | 146.68B | 8.86B | 9.17B | 8.80B | 9.05B |
| Cash & Equivalents | 204.57B | 166.14B | 96.14B | 69.11B | 61.05B |
| Current Assets | 455.10B | 413.60B | 345.10B | 281.27B | 247.64B |
| Current Liabilities | 148.30B | 103.62B | 122.93B | 65.93B | 93.73B |
Puntuaciones de Estrategias
This stock passed the criteria for 2 strategies
Score = fit strength (0–100)
Rank = position among all matches
#155 of 820
#373 of 708
Actividad Reciente
Entró
Deep Value Investing (Seth Klarman)
Mar 24, 2026
Entró
Defensive Investing (Benjamin Graham)
Mar 24, 2026